Videos
Michael Gertner, Olympic Ophthalmics CEO, describes the company’s iTEAR neuromodulation device for dry eye as “a game changer” in this video from OIS@ASCRS. He also…
Read MoreIn this video, Bernhard Günther, president of Novaliq, discusses the benefits of EyeSol, the company’s water-free technology, over traditional water-based technologies. The firm currently has…
Read MoreNicox SA CEO and chairman Michele Garufi describes the company’s glaucoma-focused pipeline, drawing on its nitric-oxide platform. He explains how NO works in animal models…
Read MoreLaurent Attias, SVP of freshly spun-off Alcon, talks up an agnostic approach to innovation in this interview with OIS TV’s Ehsan Sadri, MD, adding the…
Read MoreDr. Daniel Durrie is an internationally recognized refractive surgeon and has performed over 50,000 refractive procedures in his career. He is the founder of Durrie…
Read MoreSusan Orr, CEO speaks for Notal Vision during the Innovative Showcase at OIS@AAO 2019. REGISTER for our next ophthalmology conference today http://bit.ly/2yFA6cv.
Read MoreVizzario is developing an artificial intelligence platform that performs computer modeling of common eye diseases. Founder and CEO Khizer Khaderi, MD, a neuro-ophthalmologist, explains that…
Read MoreIn addition to bringing us up to date on Aerie Pharmaceuticals’ progress, Thomas A. Mitro, president and COO, sheds some light on his path to…
Read MoreChuck Hess, vice president and general manager at Bausch + Lomb, updates us on the company’s growing Stellaris Elite and Vitesse platforms as well as…
Read MoreYari Mitchell, vice president of medical affairs and business strategy at AcuFocus, updates OIS.TV on the progress of the Kamra Inlay and the promise of…
Read MoreDave Van Meter, president and CEO of Ivantis, explains how the company’s Hydrus Microstent plans to grab a piece of the growing MIGS market. He…
Read MoreThomas Frinzi, worldwide president, surgical, Johnson & Johnson Vision, shares some impressive milestones for the company’s Symfony and Symfony Toric IOLs. He also discusses the…
Read MoreSUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.